Free Trial

NEXGEL Q4 2024 Earnings Report

NEXGEL logo
$2.88 -0.17 (-5.57%)
As of 03/28/2025 04:00 PM Eastern

NEXGEL EPS Results

Actual EPS
-$0.08
Consensus EPS
-$0.10
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

NEXGEL Revenue Results

Actual Revenue
$3.04 million
Expected Revenue
$2.99 million
Beat/Miss
Beat by +$48.00 thousand
YoY Revenue Growth
N/A

NEXGEL Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

NEXGEL Earnings Headlines

NEXGEL, Inc. (NASDAQ:NXGL) Q4 2024 Earnings Call Transcript
Don’t buy TSLA stock until you see this
After a surprise all-hands meeting, Elon Musk urged everyone to “hang onto your stock”... Sparking a rebound of around 10% on Tesla (TSLA) stock this past Monday. Leaving many investors pondering whether or not to buy into a position. That is exactly why I am stepping forward this Sunday, March 30th at 1 PM ET.
NEXGEL Reports Record Revenue Growth in 2024
See More NEXGEL Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NEXGEL? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NEXGEL and other key companies, straight to your email.

About NEXGEL

NEXGEL (NASDAQ:NXGL) manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

View NEXGEL Profile

More Earnings Resources from MarketBeat